School of Medicine

Researchers at Washington University School of Medicine​ in St. Louis have identified “broadly neutralizing” antibodies that protect against infection by multiple, distantly related alphaviruses – including Chikungunya virus – that cause fever and debilitating joint pain. The discovery, in mice, lays the groundwork for a single vaccine or antibody-based treatment against many different alphaviruses.

High-dose vitamin D relieves joint and muscle pain for many breast cancer patients taking estrogen-lowering drugs, according to a new study from Washington University School of Medicine in St. Louis.

Though he doesn’t consider himself a pathfinder, James L. Sweatt helped integrate some of the country’s top institutions, including Washington University School of Medicine.

Leading Together benefits our community, our nation and our global society.

For Kathy Grange, MD, every day is a professional adventure, solving medical mysteries and pursuing diagnoses of rare diseases. A professor of pediatrics, Grange is director of the Division of Genetics and Genomic Medicine in the Department of Pediatrics.

The Burroughs Wellcome Fund has recognized two researchers at the School of Medicine for their studies in pulmonary medicine and cardiology. The two — among 14 scientists selected nationally to receive the BWF 2015 Career Award for Medical Scientists — are Jennifer Alexander-Brett, MD, PhD, and Kory J. Lavine, MD, PhD.

​Melody Goodman, PhD, an assistant professor of surgery at Washington University School of Medicine and a research member of Siteman Cancer Center, has been appointed to the City of St. Louis Board of Health and Hospitals.

Shashikant Kulkarni, PhD, an associate professor of pathology and immunology at the School of Medicine, has been named editor-in-chief of the journal Cancer Genetics.​​​​

Researchers at the School of Medicine have been awarded $13.7 million from the National Cancer Institute (NCI) to create new therapies for multiple myeloma, a cancer of the immune system.​ Led by Samuel Achilefu, PhD, (pictured) and Gregory Lanza, MD, PhD, at the newly created Center for Multiple Myeloma Nanotherapy, scientists will work to develop nanomaterials and drugs to treat the disease.

Emil R. Unanue, MD, an internationally renowned immunologist at the School of Medicine, has received a Sanofi-Institut Pasteur Award for his invaluable contributions to the field of immunology. The annual awards honor scientists who have made outstanding contributions to biomedical research in fields that profoundly affect global health.